Mast cells, basophils and B cell connection network

Molecular Immunology

Volumn 63, Issue 1, 2015, Pages 94-103

  Merluzzi, Sonia ^a   Betto, Elena ^b   Ceccaroni, Alice Amaranta ^b   Magris, Raffaella ^b   Giunta, Marina ^c   Mion, Francesca ^b  

^a San Antonio Hospital   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

B cells; Basophils; Mast cells

Indexed keywords

CHEMOKINE; CYTOKINE;

ADAPTIVE IMMUNITY; B CELL MALIGNANCY; B LYMPHOCYTE; BASOPHIL; CANCER GROWTH; CANCER SURVIVAL; CELL COMMUNICATION; CELL INTERACTION; EXOSOME; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; MAST CELL; NEOPLASM; NONHUMAN; REVIEW; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; IMMUNOLOGY; NEOVASCULARIZATION (PATHOLOGY);

B-LYMPHOCYTES; BASOPHILS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINES; EXOSOMES; HUMANS; MAST CELLS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84908455297     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.02.016     Document Type: Review

References (136)

1. Akin C., Jaffe E.S., Raffeld M., Kirshenbaum A.S., Daley T., Noel P., Metcalfe D.D. An immunohistochemical study of the bone marrow lesions of systemic mastocytosis: expression of stem cell factor by lesional mast cells. Am. J. Clin. Pathol. 2002, 118:242-247.
2. Amin K. The role of mast cells in allergic inflammation. Respir. Med. 2012, 106:9-14.
3. Banu Y., Watanabe T. Augmentation of antigen receptor-mediated responses by histamine H1 receptor signaling. J. Exp. Med. 1999, 189:673-682.
4. Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 2011, 11:34-46.
5. Bemark M., Boysen P., Lycke N.Y. Induction of gut IgA production through T cell-dependent and T cell-independent pathways. Ann. NY. Acad. Sci. 2012, 1247:97-116.
6. Bertolini F., Mancuso P., Gobbi A., Pruneri G. The thin red line: angiogenesis in normal and malignant hematopoiesis. Exp. Hematol. 2000, 28:993-1000.
7. Blanchet M.R., Maltby S., Haddon D.J., Merkens H., Zbytnuik L., McNagny K.M. CD34 facilitates the development of allergic asthma. Blood 2007, 110:2005-2012.
8. Blank U., Falcone F.H., Nilsson G. The history of mast cell and basophil research - some lessons learnt from the last century. Allergy 2013, 68:1093-1101.
9. Bonecchi R., Galliera E., Borroni E.M., Corsi M.M., Locati M., Mantovani A. Chemokines and chemokine receptors: an overview. Front Biosci (Landmark Ed) 2009, 14:540-551.
10. Camussi G., Deregibus M.C., Bruno S., Cantaluppi V., Biancone L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int. 2010, 78:838-848.
11. Cerutti A., Puga I., Cols M. New helping friends for B cells. Eur. J. Immunol. 2012, 42:1956-1968.
12. Charles N., Hardwick D., Daugas E., Illei G.G., Rivera J. Basophils and the T helper 2 environment can promote the development of lupus nephritis. Nat. Med. 2010, 16:701-707.
13. K. Chen, W., Xu, M., Wilson, B., He, N.W., Miller, E., Bengten, E.S., Edholm, P.A., Santini, P., Rath, A., Chiu, M., Cattalini, J., Litzman, B.B., J, B., Huang, A., Meini, K., Riesbeck, C. Cunningham-Rundles, A., Plebani, A., Cerutti, Immunoglobulin D. enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils, Nat Immunol 10 (2009) 889-898.
14. Chirumbolo S. State-of-the-art review about basophil research in immunology and allergy: is the time right to treat these cells with the respect they deserve?. Blood Transfus 2012, 10:148-164.
15. Cong Y., Feng T., Fujihashi K., Schoeb T.R., Elson C.O. A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota. P. Natl. Acad. Sci. USA. 2009, 106:19256-19261.
16. Corthesy B. Roundtrip ticket for secretory IgA: role in mucosal homeostasis?. J. Immunol. 2007, 178:27-32.
17. Crivellato E., Travan L., Ribatti D. Mast cells and basophils: a potential link in promoting angiogenesis during allergic inflammation. Int. Arch. Allergy Immunol. 2010, 151:89-97.
18. Crivellato E., Nico B., Ribatti D. The history of the controversial relationship between mast cells and basophils. Immunol. Lett. 2011, 141:10-17.
19. Danese S., Sans M., Fiocchi C. The CD40/CD40L costimulatory pathway in inflammatory bowel disease. Gut 2004, 53:1035-1043.
20. D'Arena G., Laurenti L., Minervini M.M., Deaglio S., Bonello L., De Martino L., De Padua L., Savino L., Tarnani M., De Feo V., Cascavilla N. Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease. Leuk. Res. 2011, 35:363-368.
21. Dave S.S., Wright G., Tan B., Rosenwald A., Gascoyne R.D., Chan W.C., Fisher R.I., Braziel R.M., Rimsza L.M., Grogan T.M., Miller T.P., LeBlanc M., Greiner T.C., Weisenburger D.D., Lynch J.C., Vose J., Armitage J.O., Smeland E.B., Kvaloy S., Holte H., Delabie J., Connors J.M., Lansdorp P.M., Ouyang Q., Lister T.A., Davies A.J., Norton A.J., Muller-Hermelink H.K., Ott G., Campo E., Montserrat E., Wilson W.H., Jaffe E.S., Simon R., Yang L., Powell J., Zhao H., Goldschmidt N., Chiorazzi M., Staudt L.M. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N. Engl. J. Med. 2004, 351:2159-2169.
22. de Jong D., Enblad G. Inflammatory cells and immune microenvironment in malignant lymphoma. J. Intern. Med. 2008, 264:528-536.
23. Denzel A., Maus U.A., Rodriguez Gomez M., Moll C., Niedermeier M., Winter C., Maus R., Hollingshead S., Briles D.E., Kunz-Schughart L.A., Talke Y., Mack M. Basophils enhance immunological memory responses. Nat. Immun. 2008, 9:733-742.
24. Dethlefsen S.M., Matsuura N., Zetter B.R. Mast cell accumulation at sites of murine tumor implantation: implications for angiogenesis and tumor metastasis. Invas. Metast. 1994-1995, 14:395-408.
25. Du S., Rashidi H.H., Le D.T., Kipps T.J., Broome H.E., Wang H.Y. Systemic mastocytosis in association with chronic lymphocytic leukemia and plasma cell myeloma. Int. J. Clin. Exp. Pathol. 2010, 3:448-457.
26. Dunn G.P., Old L.J., Schreiber R.D. The three Es of cancer immunoediting. Annu. Rev. Immun. 2004, 22:329-360.
27. Dvorak H.F. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J. Clin. Oncol. 2002, 20:4368-4380.
28. Dvorak A.M. Ultrastructural studies of human basophils and mast cells. J. Histochem. Cytochem. 2005, 53:1043-1070.
29. Ekstrom K., Valadi H., Sjostrand M., Malmhall C., Bossios A., Eldh M., Lotvall J. Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells. J. Extracell Vesicles 2012, 1.
30. Falcone F.H., Haas H., Gibbs B.F. The human basophil: a new appreciation of its role in immune responses. Blood 2000, 96:4028-4038.
31. Falus A. Interleukin-6 biosynthesis is increased by histamine in human B-cell and glioblastoma cell lines. Immunology 1993, 78:193-196.
32. Fischer M., Juremalm M., Olsson N., Backlin C., Sundstrom C., Nilsson K., Enblad G., Nilsson G. Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue. Int. J. Cancer 2003, 107:197-201.
33. Fischer M., Harvima I.T., Carvalho R.F., Moller C., Naukkarinen A., Enblad G., Nilsson G. Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion. J. Clin. Invest. 2006, 116:2748-2756.
34. Forsgren A., Brant M., Karamehmedovic M., Riesbeck K. The immunoglobulin D-binding protein MID from Moraxella catarrhalis is also an adhesin. Infect. Immun. 2003, 71:3302-3309.
35. Fox M.F., Pontier A., Gurbuxani S., Sipkins D.A. Stem cell factor expression in B cell malignancies is influenced by the niche. Leuk. Lymphoma 2013, 54:2274-2280.
36. Frossi B., De Carli M., Pucillo C. The mast cell: an antenna of the microenvironment that directs the immune response. J. Leukocyte Biol. 2004, 75:579-585.
37. Frossi B., Gri G., Tripodo C., Pucillo C. Exploring a regulatory role for mast cells: 'MCregs'?. Trends Immunol. 2010, 31:97-102.
38. Fukami H., Okunishi H., Miyazaki M. Chymase: its pathophysiological roles and inhibitors. Curr. Pharm. Des. 1998, 4:439-453.
39. Galinsky D.S., Nechushtan H. Mast cells and cancer-no longer just basic science. Crit. Rev. Oncol. Hematol. 2008, 68:115-130.
40. Galli S.J., Nakae S., Tsai M. Mast cells in the development of adaptive immune responses. Nat. Immunol. 2005, 6:135-142.
41. Gauchat J.F., Henchoz S., Mazzei G., Aubry J.P., Brunner T., Blasey H., Life P., Talabot D., Flores-Romo L., Thompson J., et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 1993, 365:340-343.
42. Glimelius I., Edstrom A., Fischer M., Nilsson G., Sundstrom C., Molin D., Amini R.M., Enblad G. Angiogenesis and mast cells in Hodgkin lymphoma. Leukemia 2005, 19:2360-2362.
43. Gooch J.L., Lee A.V., Yee D. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells. Cancer Res. 1998, 58:4199-4205.
44. Gordon J.R., Galli S.J. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 1990, 346:274-276.
45. Gri G., Frossi B., D'Inca F., Danelli L., Betto E., Mion F., Sibilano R., Pucillo C. Mast cell: an emerging partner in immune interaction. Front Immunol. 2012, 3:120.
46. Grimbaldeston M.A., Nakae S., Kalesnikoff J., Tsai M., Galli S.J. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat. Immunol. 2007, 8:1095-1104.
47. Gyorgy B., Szabo T.G., Pasztoi M., Pal Z., Misjak P., Aradi B., Laszlo V., Pallinger E., Pap E., Kittel A., Nagy G., Falus A., Buzas E.I. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol. Life. Sci. 2011, 68:2667-2688.
48. Hedstrom G., Berglund M., Molin D., Fischer M., Nilsson G., Thunberg U., Book M., Sundstrom C., Rosenquist R., Roos G., Erlanson M., Amini R.M., Enblad G. Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma. Br. J. Haematol. 2007, 138:68-71.
49. Heneberg P. Mast cells and basophils: trojan horses of conventional lin- stem/progenitor cell isolates. Curr. Pharm. Des. 2011, 17:3753-3771.
50. Henz B.M., Maurer M., Lippert U., Worm M., Babina M. Mast cells as initiators of immunity and host defense. Exp. Dermatol. 2001, 10:1-10.
51. Ho A.W., Hatjiharissi E., Ciccarelli B.T., Branagan A.R., Hunter Z.R., Leleu X., Tournilhac O., Xu L., O'Connor K., Manning R.J., Santos D.D., Chemaly M., Patterson C.J., Soumerai J.D., Munshi N.C., McEarchern J.A., Law C.L., Grewal I.S., Treon S.P. CD27-CD70 interactions in the pathogenesis of Waldenström macroglobulinemia. Blood 2008, 112:4683-4689.
52. Hong G.U., Park B.S., Park J.W., Kim S.Y., Ro J.Y. IgE production in CD40/CD40L cross-talk of B and mast cells and mediator release via TGase 2 in mouse allergic asthma. Cell Signal 2013, 25:1514-1525.
53. Hsu C.L., Neilsen C.V., Bryce P.J. IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS One 2010, 5:e11944.
54. Huang B., Lei Z., Zhang G.M., Li D., Song C., Li B., Liu Y., Yuan Y., Unkeless J., Xiong H., Feng Z.H. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 2008, 112:1269-1279.
55. Jabara H.H., Fu S.M., Geha R.S., Vercelli D. CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 1990, 172:1861-1864.
56. Janeway C. Immunobiology: the immune system in health and disease 2005, Garland Science, New York. 6th ed.
57. Kimata H., Fujimoto M., Ishioka C., Yoshida A. Histamine selectively enhances human immunoglobulin E (IgE) and IgG4 production induced by anti-CD58 monoclonal antibody. J. Exp. Med. 1996, 184:357-364.
58. Komai-Koma M., Gilchrist D.S., McKenzie A.N., Goodyear C.S., Xu D., Liew F.Y. IL-33 activates B1 cells and exacerbates contact sensitivity. J. Immunol. 2011, 186:2584-2591.
59. Kunder C.A., St John A.L., Li G., Leong K.W., Berwin B., Staats H.F., Abraham S.N. Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J. Exp. Med. 2009, 206:2455-2467.
60. LeBien T.W., Tedder T.F. B lymphocytes: how they develop and function. Blood 2008, 112:1570-1580.
61. Lin W.W., Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 2007, 117:1175-1183.
62. Lu X., Nechushtan H., Ding F., Rosado M.F., Singal R., Alizadeh A.A., Lossos I.S. Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas. Blood 2005, 105:2924-2932.
63. Lu L.F., Lind E.F., Gondek D.C., Bennett K.A., Gleeson M.W., Pino-Lagos K., Scott Z.A., Coyle A.J., Reed J.L., Van Snick J., Strom T.B., Zheng X.X., Noelle R.J. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006, 442:997-1002.
64. Mackay F., Schneider P. Cracking the BAFF code. Nat. Rev. Immunol. 2009, 9:491-502.
65. Maddur M.S., Kaveri S.V., Bayry J. Basophils as antigen presenting cells. Trends Immunol. 2010, 31:45-48.
66. Malbec O., Daeron M. The mast cell IgG receptors and their roles in tissue inflammation. Immunol. Rev. 2007, 217:206-221.
67. Maltby S., Khazaie K., McNagny K.M. Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation. Biochim. Biophys. Acta 2009, 1796:19-26.
68. Martin F., Oliver A.M., Kearney J.F. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001, 14:617-629.
69. Maurer M., Theoharides T., Granstein R.D., Bischoff S.C., Bienenstock J., Henz B., Kovanen P., Piliponsky A.M., Kambe N., Vliagoftis H., Levi-Schaffer F., Metz M., Miyachi Y., Befus D., Forsythe P., Kitamura Y., Galli S. What is the physiological function of mast cells?. Exp. Dermatol. 2003, 12:886-910.
70. Merluzzi S., Moretti M., Altamura S., Zwollo P., Sigvardsson M., Vitale G., Pucillo C. CD40 stimulation induces Pax5/BSAP and EBF activation through a APE/Ref-1-dependent redox mechanism. J. Biol. Chem. 2004, 279:1777-1786.
71. Merluzzi S., Frossi B., Gri G., Parusso S., Tripodo C., Pucillo C. Mast cells enhance proliferation of B lymphocytes and drive their differentiation toward IgA-secreting plasma cells. Blood 2010, 115:2810-2817.
72. Metcalfe D.D., Baram D., Mekori Y.A. Mast cells. Physiol. Rev. 1997, 77:1033-1079.
73. Metz M., Maurer M. Mast cells--key effector cells in immune responses. Trends Immunol. 2007, 28:234-241.
74. Mizuno H., Nakayama T., Miyata Y., Saito S., Nishiwaki S., Nakao N., Takeshita K., Naoe T. Mast cells promote the growth of Hodgkin's lymphoma cell tumor by modifying the tumor microenvironment that can be perturbed by bortezomib. Leukemia 2012, 26:2269-2276.
75. Molica S., Vacca A., Crivellato E., Cuneo A., Ribatti D. Tryptase-positive mast cells predict clinical outcome of patients with early B-cell chronic lymphocytic leukemia. Eur. J. Haematol. 2003, 71:137-139.
76. Molin D., Fischer M., Xiang Z., Larsson U., Harvima I., Venge P., Nilsson K., Sundstrom C., Enblad G., Nilsson G. Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease. Br. J. Haematol. 2001, 114:616-623.
77. Molin D., Edstrom A., Glimelius I., Glimelius B., Nilsson G., Sundstrom C., Enblad G. Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma. Br. J. Haematol. 2002, 119:122-124.
78. Murdoch C., Muthana M., Coffelt S.B., Lewis C.E. The role of myeloid cells in the promotion of tumour angiogenesis. Nat. Rev. Cancer 2008, 8:618-631.
79. Nakayama T., Yao L., Tosato G. Mast cell-derived angiopoietin-1 plays a critical role in the growth of plasma cell tumors. J. Clin. Invest. 2004, 114:1317-1325.
80. Oettgen H.C. Regulation of the IgE isotype switch: new insights on cytokine signals and the functions of epsilon germline transcripts. Curr. Opin. Immunol. 2000, 12:618-623.
81. Oflazoglu E., Grewal I.S., Gerber H. Targeting CD30/CD30L in oncology and autoimmune and inflammatory diseases. Adv. Exp. Med. Biol. 2009, 647:174-185.
82. Parmley R.T., Spicer S.S., Wright N.J. The ultrastructural identification of tissue basophils and mast cells in Hodgkin's disease. Lab Invest. 1975, 32:469-475.
83. Pawankar R., Okuda M., Yssel H., Okumura K., Ra C. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J. Clin. Invest. 1997, 99:1492-1499.
84. Pejler G., Ronnberg E., Waern I., Wernersson S. Mast cell proteases: multifaceted regulators of inflammatory disease. Blood 2010, 115:4981-4990.
85. Piconese S., Gri G., Tripodo C., Musio S., Gorzanelli A., Frossi B., Pedotti R., Pucillo C.E., Colombo M.P. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. Blood 2009, 114:2639-2648.
86. Preud'homme J.L., Petit I., Barra A., Morel F., Lecron J.C., Lelievre E. Structural and functional properties of membrane and secreted IgD. Mol. Immunol. 2000, 37:871-887.
87. Raposo G., Nijman H.W., Stoorvogel W., Liejendekker R., Harding C.V., Melief C.J., Geuze H.J. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 1996, 183:1161-1172.
88. Ribatti D., Crivellato E. The controversial role of mast cells in tumor growth. Int. Rev. Cell Mol. Biol. 2009, 275:89-131.
89. Ribatti D., Crivellato E. Immune cells and angiogenesis. J. Cell. Mol. Med. 2009, 13:2822-2833.
90. Ribatti D., Contino R., Tursi A. Do mast cells intervene in the vasoproliferative process of the rheumatoid synovitis?. J. Submicr. Cytol. Path. 1988, 20:635-637.
91. Ribatti D., Vacca A., Nico B., Quondamatteo F., Ria R., Minischetti M., Marzullo A., Herken R., Roncali L., Dammacco F. Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br. J. Cancer 1999, 79:451-455.
92. Ribatti D., Vacca A., Nico B., Crivellato E., Roncali L., Dammacco F. The role of mast cells in tumour angiogenesis. Br. J. Haematol. 2001, 115:514-521.
93. Rivera J., Gilfillan A.M. Molecular regulation of mast cell activation. J. Allergy Clin. Immun. 2006, 117:1214-1225. quiz 1226.
94. Rodriguez Gomez M., Talke Y., Goebel N., Hermann F., Reich B., Mack M. Basophils support the survival of plasma cells in mice. J. Immunol. 2010, 185:7180-7185.
95. Ronander E., Brant M., Janson H., Sheldon J., Forsgren A., Riesbeck K. Identification of a novel Haemophilus influenzae protein important for adhesion to epithelial cells. Microbes Infect. 2008, 10:87-96.
96. Rudich N., Ravid K., Sagi-Eisenberg R. Mast cell adenosine receptors function: a focus on the a3 adenosine receptor and inflammation. Front Immunol. 2012, 3:134.
97. Ryzhov S., Goldstein A.E., Matafonov A., Zeng D., Biaggioni I., Feoktistov I. Adenosine-activated mast cells induce IgE synthesis by B lymphocytes: an A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma. J. Immunol. 2004, 172:7726-7733.
98. Satodate R., Schwarze E.W., Lennert K. [Tissue mast cell count in immunocytoma and chronic lymphocytic leukaemia (author's transl)]. Virchows Arch. A. Pathol. Anat. Histol. 1977, 373:303-309.
99. Sayed B.A., Christy A., Quirion M.R., Brown M.A. The master switch: the role of mast cells in autoimmunity and tolerance. Annu. Rev. Immunol. 2008, 26:705-739.
100. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., Zurawski G., Moshrefi M., Qin J., Li X., Gorman D.M., Bazan J.F., Kastelein R.A. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
101. Schneider E., Thieblemont N., De Moraes M.L., Dy M. Basophils: new players in the cytokine network. Eur. Cytokine Netw. 2010, 21:142-153.
102. Schneider E., Bertron A.F., Dy M. Modulation of hematopoiesis through histamine receptor signaling. Front Biosci. (Schol Ed) 2011, 3:467-473.
103. Schonbeck U., Libby P. The CD40/CD154 receptor/ligand dyad. Cell. Mol. Life Sci. 2001, 58:4-43.
104. Shapira S.K., Vercelli D., Jabara H.H., Fu S.M., Geha R.S. Molecular analysis of the induction of immunoglobulin E synthesis in human B cells by interleukin 4 and engagement of CD40 antigen. J. Exp. Med. 1992, 175:289-292.
105. Shefler I., Salamon P., Hershko A.Y., Mekori Y.A. Mast cells as sources and targets of membrane vesicles. Curr. Pharm. Des. 2011, 17:3797-3804.
106. Shin K., Nigrovic P.A., Crish J., Boilard E., McNeil H.P., Larabee K.S., Adachi R., Gurish M.F., Gobezie R., Stevens R.L., Lee D.M. Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. J. Immunol. 2009, 182:647-656.
107. Skokos D., Le Panse S., Villa I., Rousselle J.C., Peronet R., David B., Namane A., Mecheri S. Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J. Immunol. 2001, 166:868-876.
108. Skokos D., Le Panse S., Villa I., Rousselle J.C., Peronet R., Namane A., David B., Mecheri S. Nonspecific B and T cell-stimulatory activity mediated by mast cells is associated with exosomes. Int. Arch. Allergy Immunol. 2001, 124:133-136.
109. Starkey J.R., Crowle P.K., Taubenberger S. Mast-cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis. Int. J. Cancer 1988, 42:48-52.
110. Stavnezer J., Guikema J.E., Schrader C.E. Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 2008, 26:261-292.
111. Stelekati E., Orinska Z., Bulfone-Paus S. Mast cells in allergy: innate instructors of adaptive responses. Immunobiology 2007, 212:505-519.
112. Stone M.J., Pascual V. Pathophysiology of Waldenstrom's macroglobulinemia. Haematologica 2010, 95:359-364.
113. Stone K.D., Prussin C., Metcalfe D.D. IgE, mast cells, basophils, and eosinophils. J. Allergy Clin. Immun. 2010, 125:S73-S80.
114. Subra C., Grand D., Laulagnier K., Stella A., Lambeau G., Paillasse M., De Medina P., Monsarrat B., Perret B., Silvente-Poirot S., Poirot M., Record M. Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. J. Lipid Res. 2010, 51:2105-2120.
115. Thery C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 2009, 9:581-593.
116. Taskinen M., Karjalainen-Lindsberg M.L., Leppa S. Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with rituximab and CHOP. Blood 2008, 111:4664-4667.
117. Tchougounova E., Lundequist A., Fajardo I., Winberg J.O., Abrink M., Pejler G. A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J. Biol. Chem. 2005, 280:9291-9296.
118. Theoharides T.C., Conti P. Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol. 2004, 25:235-241.
119. Theoharides T.C., Kempuraj D., Tagen M., Conti P., Kalogeromitros D. Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol. Rev. 2007, 217:65-78.
120. Tkaczyk C., Frandji P., Botros H.G., Poncet P., Lapeyre J., Peronet R., David B., Mecheri S. Mouse bone marrow-derived mast cells and mast cell lines constitutively produce B cell growth and differentiation activities. J. Immunol. 1996, 157:1720-1728.
121. Tokuhira M., Watanabe R., Iizuka A., Sekiguchi Y., Nemoto T., Hanzawa K., Takamatsu I., Maruyama T., Tamaru J., Itoyama S., Suzuki H., Takeuchi T., Mori S. De novo CD5+ diffuse large B cell lymphoma with basophilia in the peripheral blood: successful treatment with autologous peripheral blood stem cell transplantation. Am. J. Hematol. 2007, 82:162-167.
122. Tournilhac O., Santos D.D., Xu L., Kutok J., Tai Y.T., Le Gouill S., Catley L., Hunter Z., Branagan A.R., Boyce J.A., Munshi N., Anderson K.C., Treon S.P. Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signaling. Ann. Oncol. 2006, 17:1275-1282.
123. Ullrich S.E., Nghiem D.X., Khaskina P. Suppression of an established immune response by UVA--a critical role for mast cells. Photochem. Photobiol. 2007, 83:1095-1100.
124. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9:654-659.
125. van Kempen L.C., Ruiter D.J., van Muijen G.N., Coussens L.M. The tumor microenvironment: a critical determinant of neoplastic evolution. Eur. J. Cell Biol. 2003, 82:539-548.
126. Vilcek J. The cytokines: an overview. The Cytokine Handbook 2003, 3-18. Academic Press, San Diego. A.W. Thomson, M.T. Lotze (Eds.).
127. Vincent-Schneider H., Thery C., Mazzeo D., Tenza D., Raposo G., Bonnerot C. Secretory granules of mast cells accumulate mature and immature MHC class II molecules. J. Cell Sci. 2001, 114:323-334.
128. Vincent-Schneider H., Stumptner-Cuvelette P., Lankar D., Pain S., Raposo G., Benaroch P., Bonnerot C. Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells. Int. Immunol. 2002, 14:713-722.
129. Voehringer D. Protective and pathological roles of mast cells and basophils. Nat. Rev. Immun. 2013, 13:362-375.
130. Wang H.W., Tedla N., Lloyd A.R., Wakefield D., McNeil P.H. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J. Clin. Invest. 1998, 102:1617-1626.
131. Wedemeyer J., Galli S.J. Mast cells and basophils in acquired immunity. Br. Med. Bull. 2000, 56:936-955.
132. Wedemeyer J., Tsai M., Galli S.J. Roles of mast cells and basophils in innate and acquired immunity. Curr. Opin. Immunol. 2000, 12:624-631.
133. Wiley S.R., Goodwin R.G., Smith C.A. Reverse signaling via CD30 ligand. J. Immunol. 1996, 157:3635-3639.
134. Yanagihara Y., Kajiwara K., Basaki Y., Ikizawa K., Ebisawa M., Ra C., Tachimoto H., Saito H. Cultured basophils but not cultured mast cells induce human IgE synthesis in B cells after immunologic stimulation. Clin. Exp. Immunol. 1998, 111:136-143.
135. Yoshikawa T., Imada T., Nakakubo H., Nakamura N., Naito K. Rat mast cell protease-I enhances immunoglobulin E production by mouse B cells stimulated with interleukin-4. Immunology 2001, 104:333-340.
136. Yoshimoto T., Yasuda K., Tanaka H., Nakahira M., Imai Y., Fujimori Y., Nakanishi K. Basophils contribute to T(H)2-IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4+ T cells. Nat. Immunol. 2009, 10:706-712.